1. Startseite
  2. Aktien
  3. Schweden
  4. Nasdaq Stockholm
  5. Xbrane Biopharma AB (publ)
  6. News
  7. Andere Sprachen
    XBRANE   SE0007789409

XBRANE BIOPHARMA AB (PUBL)

(XBRANE)
  Bericht
Realtime-Estimate Cboe Europe  -  19/05 17:25:00
78.20 SEK   -0.89%
05.05.Xbrane Biopharma AB (publ) meldet Ergebnis für das erste Quartal zum 31. März 2022
CI
24.02.Xbrane Biopharma AB (publ) meldet Ergebnis für das am 31. Dezember 2021 abgeschlossene Geschäftsjahr
CI
15.02.Xbrane Biopharma AB (Publ) gibt positive Top-Line-Ergebnisse der pivotalen Phase-III-Äquivalenzstudie für Xlucane™ bekannt - ein Biosimilar-Kandidat zu Lucentis
CI
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über XBRANE BIOPHARMA AB (PUBL)
05.05.Announcement from Xbrane Biopharma's annual general meeting
05.05.TRANSCRIPT : Xbrane Biopharma AB, Q1 2022 Earnings Call, May 05, 2022
05.05.Xbrane Biopharma releases interim report for January – March 2022
05.05.Xbrane Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2022
02.05.Invitation to presentation of Xbrane Biopharma's interim report January – March 2..
05.04.Correction regarding notice of annual general meeting in Xbrane Biopharma
04.04.Notice of annual general meeting in Xbrane Biopharma AB
31.03.Xbrane Biopharma releases annual report 2021
09.03.Xbrane Biopharma - Xciting and Increasingly Compelling Case
24.02.TRANSCRIPT : Xbrane Biopharma AB, Q4 2021 Earnings Call, Feb 24, 2022
24.02.Xbrane Biopharma releases Year-end report 2021
24.02.Xbrane Biopharma AB Reports Earnings Results for the Full Year Ended December 31, 2021
23.02.Invitation to presentation of xbrane biopharma's year-end report 2021 on february 24, 2..
22.02.Invitation to presentation of Xbrane Biopharma's Year-end report 2021 on February 24, 2..
17.02.Biogen And Xbrane Enter Into Worldwide Commercialization And License Agreement For Cert..
17.02.Xbrane provides an update on its subsidiary Primm Pharma
16.02.Xbrane announces positive top-line results from the pivotal phase iii equivalence trial..
15.02.Xbrane announces positive top-line results from the pivotal phase III equivalence trial..
15.02.Xbrane Biopharma AB Announces Positive Top-Line Results from the Pivotal Phase III Equi..
08.02.Biogen and xbrane announce commercialization and license agreement for proposed biosimi..
08.02.TRANSCRIPT : Xbrane Biopharma AB - Special Call
07.02.Xbrane invites to a webcast related to the announcement of the commercialization and li..
07.02.Biogen and Xbrane Announce Commercialization and License Agreement for Proposed Biosimi..
07.02.Biogen Inc. and Xbrane Biopharma AB Announce Commercialization and License Agreement fo..
18.01.Xbrane Biopharma changes the date for Interim and Year-end Report
04.01.XBRANE BIOPHARMA AB(OM : XBRANE) dropped from OMX Nordic Small Cap Index
2021Certain Shares of Xbrane Biopharma AB are subject to a Lock-Up Agreement Ending on 28-D..
2021Xbrane Biopharma moves to Nasdaq Stockholm Mid Cap segment
2021Xbrane has initiated development of two new biosimilar candidates, building an oncology..
2021TRANSCRIPT : Xbrane Biopharma AB - Special Call
2021Xbrane has initiated development of two new biosimilar candidates, building an oncology..
2021Xbrane Biopharma releases interim report for January - September 2021
2021Invitation to presentation of xbrane biopharma's interim report january - september, 20..
2021TRANSCRIPT : Xbrane Biopharma AB, Nine Months 2021 Earnings Call, Oct 29, 2021
2021Interim Report January – September 2021
2021Xbrane Biopharma releases interim report for January – September 2021
2021Xbrane Biopharma AB Reports Earnings Results for the Third Quarter and Nine Months Ende..
2021Invitation to presentation of Xbrane Biopharma's interim report January – Septemb..
2021Xbrane announces four more patents granted
2021XBRANE BIOPHARMA : presents Nomination Committee
2021Xbrane Biopharma Presents Nomination Committee
2021XBRANE BIOPHARMA : announces two granted patents that strengthens its high yield protein e..
2021Xbrane Biopharma AB announces two granted patents that strengthens its high yield prote..
2021XBRANE BIOPHARMA : enters agreement with AGC Biologics
2021XBRANE BIOPHARMA : and AGC Biologics enter into an Agreement to Manufacture Xcimzane&trade..
2021Xbrane Biopharma AB and AGC Biologics Enter into an Agreement to Manufacture Xcimzane™ ..
2021XBRANE BIOPHARMA AB : announces that partner STADA's Marketing Authorization Application f..
2021Certain Shares of Xbrane Biopharma AB are subject to a Lock-Up Agreement Ending on 29-S..
2021XBRANE BIOPHARMA AB(OM : XBRANE) added to S&P Global BMI Index
2021XBRANE BIOPHARMA : Releases interim report for january - june 2021
2021TRANSCRIPT : Xbrane Biopharma AB, H1 2021 Earnings Call, Aug 13, 2021
2021XBRANE BIOPHARMA : Interim Report January – June 2021
2021XBRANE BIOPHARMA : releases interim report for January – June 2021
2021Xbrane Biopharma AB Publ Reports Earnings Results for the Second Quarter Ended June 30,..
2021XBRANE BIOPHARMA : Invitation to presentation of Xbrane Biopharma's interim report January..
2021XBRANE BIOPHARMA : A bright future
2021XBRANE BIOPHARMA : Change of number of shares and votes in Xbrane
2021XBRANE BIOPHARMA : certified as a Great Place to Work®
2021XBRANE BIOPHARMA : has carried out a directed share issue raising gross proceeds of SEK 38..
2021XBRANE BIOPHARMA : announces intention to carry out a directed share issue
2021XBRANE BIOPHARMA : Change of number of shares and votes in xbrane
2021XBRANE BIOPHARMA : XlucaneTM meets the primary endpoint in the pivotal Phase III trial wit..
2021XBRANE BIOPHARMA : Xlucane™ meets the primary endpoint in the pivotal Phase III tria..
2021Xbrane Biopharma AB Announces Top-Line Results from the 6 Months Interim Read-Out in th..
2021XBRANE BIOPHARMA : announces ambition to generate positive operating cash flow monthly by ..
2021XBRANE BIOPHARMA : is hosting a Virtual Capital Markets Day on May 17th, 2021
2021Certain Shares of Xbrane Biopharma AB are subject to a Lock-Up Agreement Ending on 10-M..
2021XBRANE BIOPHARMA : Announcement from Xbrane Biopharma's annual general meeting
2021XBRANE BIOPHARMA : Announcement from Xbrane Biopharma's annual general meeting
2021XBRANE BIOPHARMA : releases interim report for January – March 2021
2021Xbrane Biopharma AB Publ Reports Earnings Results for the First Quarter Ended March 31,..
2021XBRANE BIOPHARMA : Invitation to presentation of Xbrane Biopharma's interim report January..
2021XBRANE BIOPHARMA : expands in-house Biosimilar development capabilities with new Biotech l..
2021XBRANE BIOPHARMA : releases Annual report for 2020
2021Xbrane Biopharma AB Auditor Raises 'Going Concern' Doubt
1  2  3Weiter
Anstehende Termine für XBRANE BIOPHARMA AB (PUBL)